Developer docs
API playgroundTry for free, no card

Search company profiles

Immune Deficiency Foundation

Full company profile

uuid0009oaj

Namestring
Immune Deficiency Foundation
Legal namestring
Immune Deficiency Foundation
Company typeenum
Private
Founded yearint
1980
Descriptiontext

Immune Deficiency Foundation (IDF) is a 501(c)(3) nonprofit patient organization founded in 1980 and headquartered in Hanover, Maryland (EIN 52-1214782), dedicated to improving the diagnosis, treatment, and quality of life for individuals and families affected by primary immunodeficiency (PI) — a class of more than 550 rare inborn errors of immunity affecting an estimated 1 in every 1,600–1,700 people in the U.S. The organization operates a comprehensive, multi-channel service portfolio that spans four functional pillars: education (the Patient & Family Handbook, IDF Podcast with sub-series like Undiagnosed and Bold Conversations, the Immune System Self-Assessment tool, and the 'Compromised: Life Without Immunity' documentary), direct support (AskIDF expert consultations, IDF Friends online community at idffriends.org, and Get Connected peer support groups), clinical navigation (Clinician Finder, Consulting Immunologist Program, clinician education), and research and advocacy (Research Grant Program, community surveys, SCID newborn screening advocacy, and the Immunocompromised Collaborative). According to the 2025 Community Impact Report, IDF supported 34,034 individuals living with PI, facilitated 2,226 answered questions through AskIDF, and recorded 1.8 million website sessions.

Underlying technology consists of standard digital advocacy infrastructure — a Drupal-based content website (primaryimmune.org), Salesforce-backed event listings, community forums, email and SMS subscription systems, and YouTube-hosted media — rather than proprietary technology products. IDF does not develop commercial software or scientific platforms; the technology layer exists to deliver educational content, facilitate peer connection, and enable donations and event registration.

The business model is a donation-funded, fee-free nonprofit model. All resources, support services, and educational materials are provided at no cost to patients, caregivers, and clinicians. Revenue is sourced from individual donations, legacy giving, workplace giving programs, tribute gifts, sustainer/membership giving, peer-to-peer fundraising (including Facebook fundraisers and DIY fundraisers), and Walk and Community Days events held in six U.S. cities plus virtual coast-to-coast participation. Content creator partnerships (notably CDawgVA and Ironmouse) and the Plasma Hero campaign diversify awareness and fundraising reach. GTM is mission-driven, not commercial: IDF markets itself through content marketing, organic social (Facebook, X, LinkedIn, Instagram, YouTube), email/SMS, podcasts, documentaries, in-person and virtual events, and community programming targeted at four personas — individuals living with PI (primary), caregivers/family (primary), healthcare professionals (secondary), and general supporters (secondary).

Short descriptiontext

Immune Deficiency Foundation is a 501(c)(3) nonprofit patient organization founded in 1980, dedicated to improving diagnosis, treatment, and quality of life for individuals and families affected by primary immunodeficiency (PI). It delivers free education, peer support, clinical navigation, research grants, and policy advocacy at national scale.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTowson, United States
HQ citystring
Towson
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
patient advocacy services, rare disease education, immune deficiency support, nonprofit healthcare research, community peer support
Industry3 codes
1Rare Disease & Special Needs Support Organizations
CodeBPAGACAMPrimaryYes
2Primary Immunodeficiency (PID) & Immune Deficiency Clinics
CodeHLAKAAAIPrimaryNo
3Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
CodeBPAGACAAPrimaryNo
NAICS code1 code
  • Voluntary Health Organizations813212
SIC code2 codes
  • Services-Social Services8300
  • Services-Misc Health & Allied Services, Nec8090
Product category
Nonprofit Patient Advocacy Services
Revenue model1 record
1Donations and Fundraising
TypeOthers
Description

The IDF operates as a 501(c)(3) non-profit organization (EIN: 52-1214782) that relies on donations from individuals, families, and supporters to fund its resources, services, and outreach programs.

primaryimmune.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1Think Zebra
Description

IDF's motto and awareness campaign. People with primary immunodeficiencies are like the zebras of the medical world—rare and worthy of attention and care.

primaryimmune.org
Core offering1 text field

The Immune Deficiency Foundation is a national nonprofit patient organization that improves the diagnosis, treatment, and quality of life for people with primary immunodeficiency through free educational resources (handbooks, podcasts), peer support programs (Ask IDF helpline, peer groups, IDF Friends), patient-to-clinician connection tools (clinician finder, self-assessment), awareness/fundraising campaigns (Walk for PI, Plasma Hero), and research grant funding.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

The Immune Deficiency Foundation offers a comprehensive suite of educational, support, and research services for individuals affected by primary immunodeficiency (PI). The core offerings include the IDF Patient & Family Handbook (print resource), the IDF Podcast series with sub-series Undiagnosed and Bold Conversations, and the Ask IDF expert consultation service. Community support is provided through the IDF Friends online community and Get Connected peer groups. The Foundation provides diagnostic tools including an immune system self-assessment and a Clinician Finder database. Research initiatives include a Research Grant Program and community surveys. Awareness efforts feature the Plasma Hero campaign, the annual Walk and Community Days events, and the documentary 'Compromised: Life Without Immunity' available on YouTube. All services are funded primarily through donor contributions.

Product and service10 records
1Patient & Family Handbook
CategoryPatient education resource
Description

A comprehensive educational resource that explains primary immunodeficiency diseases, treatment options such as immunoglobulin therapy, and daily living guidance for patients and their families.

2IDF Podcast
CategoryPatient education resource
Description

An audio podcast that delivers educational content, patient stories, and expert interviews to the primary immunodeficiency community.

3Ask IDF Support Service
CategoryPatient support service
Description

A direct support service that allows patients, families, and caregivers to ask questions and receive guidance on primary immunodeficiency-related issues.

4Peer Support Groups
CategoryPatient support service
Description

Peer-led support groups that connect patients and families affected by primary immunodeficiency for shared experience, encouragement, and community connection.

5IDF Friends / Get Connected Community
CategoryPatient support service
Description

A community-building program that connects patients and families affected by primary immunodeficiency through informal friendship and connection opportunities.

6IDF Research Grants Program
CategoryResearch funding
Description

A research-grant program that funds scientific investigation into primary immunodeficiency diseases to advance diagnosis, treatment, and patient outcomes.

7Walk for PI and Community Days
CategoryFundraising and awareness event
Description

Grassroots fundraising and awareness walk events held in local communities across the United States to support IDF's mission and raise primary immunodeficiency awareness.

8Plasma Hero Awareness Campaign
CategoryFundraising and awareness event
Description

A public awareness campaign that highlights the importance of plasma donors in supporting treatment for primary immunodeficiency patients and encourages plasma donation.

9Clinician Finder Tool
CategoryPatient resource tool
Description

An online directory that helps patients locate clinicians and immunologists experienced in diagnosing and treating primary immunodeficiency diseases.

10Primary Immunodeficiency Self-Assessment Tool
CategoryPatient resource tool
Description

An online self-assessment tool that helps individuals evaluate whether they may be experiencing symptoms of primary immunodeficiency and guides next steps such as clinical evaluation.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-03-13
Description

Nationwide Rare Diseases campaign launched by Mediaplanet to raise awareness, promote early diagnosis, and improve treatment options for rare diseases. Involves collaboration between researchers, patient advocates, healthcare institutions, and pharmaceutical companies.

2CDawgVA (Connor Colquhoun) and VTuber Ironmouse
Strategic tierMajorTypeGTM or Marketing Partner
Description

Content creator partnership where Connor Colquhoun (CDawgVA) and Ironmouse, a VTuber living with common variable immune deficiency (CVID), came together to support IDF. What began as a friendship has grown into one of the most impactful partnerships in content creator fundraising, helping raise awareness and funds for the immunocompromised community.

primaryimmune.org
3Immunocompromised Collaborative
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Coalition of organizations joining forces to protect the most vulnerable against infectious disease. IDF participates as a member organization working collaboratively on policy advocacy and awareness initiatives.

primaryimmune.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Also dedicated specifically to primary immunodeficiency; operates a global network of diagnostic and research centers. Closest direct peer given the shared PI-only mission, fundraising model, and research-grant funding approach.

TypeDirect peer
Description

Patient advocacy nonprofit for a single rare genetic disease with analogous programs: research grants, clinician finder, community walks, newborn screening advocacy, and significant pharma partnerships. Strong operating-model comparable despite a much larger budget.

TypeDirect peer
Description

Long-standing rare disease nonprofit running patient services, research grants, clinical care networks, and signature fundraising events (telethons, walks). Comparable mission, multi-disease research portfolio, and donor-driven model.

TypeDirect peer
Description

Umbrella advocacy organization for all rare diseases; IDF is a NORD member. Overlaps heavily in policy advocacy, research grants, and patient services but from a horizontal (all rare diseases) rather than vertical (PI-only) position.

TypeBroad incumbent
Description

Disease-specific nonprofit at much larger scale, with peer support, research grants, clinician finder, and signature fundraising events (Light The Night). Comparable playbook though it operates across blood cancers rather than a single rare category.

6American Autoimmune Related Diseases Association
TypeEmerging player
Description

Patient advocacy for autoimmune diseases, several of which overlap clinically with PI (autoimmunity is a known feature of many PI subtypes). Comparable smaller-scale nonprofit model with focus on disease-specific education and advocacy.

TypeRegional player
Description

International umbrella for PI patient organizations, including IDF's European counterparts. Comparable mission and product structure (educational resources, policy advocacy, awareness days) but operates outside the U.S. market IDF serves.

TypeRegional player
Description

Australia's PI patient organization with closely mirrored programs: Ask the IDFA, peer support, advocacy, and education. Functionally a regional twin of the U.S. IDF, providing a geographic peer benchmark.

TypeOthers
Description

Industry association representing plasma collection and fractionation companies that manufacture immunoglobulin replacement therapy used by many PI patients. Adjacent ecosystem participant rather than a competitor; relevant given IDF's Plasma Hero campaign.

TypeEmerging player
Description

Patient advocacy nonprofit for Alpha-1 antitrypsin deficiency, another rare genetic disorder often managed by immunologists. Highly comparable single-disease nonprofit operating model at a smaller scale than IDF.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Immune Deficiency Foundation

Nonprofit Patient Advocacy Servicesprimaryimmune.org

Immune Deficiency Foundation is a 501(c)(3) nonprofit patient organization founded in 1980, dedicated to improving diagnosis, treatment, and quality of life for individuals and families affected by primary immunodeficiency (PI). It delivers free education, peer support, clinical navigation, research grants, and policy advocacy at national scale.

What Immune Deficiency Foundation does

Immune Deficiency Foundation (IDF) is a 501(c)(3) nonprofit patient organization founded in 1980 and headquartered in Hanover, Maryland (EIN 52-1214782), dedicated to improving the diagnosis, treatment, and quality of life for individuals and families affected by primary immunodeficiency (PI) — a class of more than 550 rare inborn errors of immunity affecting an estimated 1 in every 1,600–1,700 people in the U.S. The organization operates a comprehensive, multi-channel service portfolio that spans four functional pillars: education (the Patient & Family Handbook, IDF Podcast with sub-series like Undiagnosed and Bold Conversations, the Immune System Self-Assessment tool, and the 'Compromised: Life Without Immunity' documentary), direct support (AskIDF expert consultations, IDF Friends online community at idffriends.org, and Get Connected peer support groups), clinical navigation (Clinician Finder, Consulting Immunologist Program, clinician education), and research and advocacy (Research Grant Program, community surveys, SCID newborn screening advocacy, and the Immunocompromised Collaborative). According to the 2025 Community Impact Report, IDF supported 34,034 individuals living with PI, facilitated 2,226 answered questions through AskIDF, and recorded 1.8 million website sessions.

Underlying technology consists of standard digital advocacy infrastructure — a Drupal-based content website (primaryimmune.org), Salesforce-backed event listings, community forums, email and SMS subscription systems, and YouTube-hosted media — rather than proprietary technology products. IDF does not develop commercial software or scientific platforms; the technology layer exists to deliver educational content, facilitate peer connection, and enable donations and event registration.

The business model is a donation-funded, fee-free nonprofit model. All resources, support services, and educational materials are provided at no cost to patients, caregivers, and clinicians. Revenue is sourced from individual donations, legacy giving, workplace giving programs, tribute gifts, sustainer/membership giving, peer-to-peer fundraising (including Facebook fundraisers and DIY fundraisers), and Walk and Community Days events held in six U.S. cities plus virtual coast-to-coast participation. Content creator partnerships (notably CDawgVA and Ironmouse) and the Plasma Hero campaign diversify awareness and fundraising reach. GTM is mission-driven, not commercial: IDF markets itself through content marketing, organic social (Facebook, X, LinkedIn, Instagram, YouTube), email/SMS, podcasts, documentaries, in-person and virtual events, and community programming targeted at four personas — individuals living with PI (primary), caregivers/family (primary), healthcare professionals (secondary), and general supporters (secondary).

Immune Deficiency Foundation firmographics

Firmographics
Name
Immune Deficiency Foundation
Legal name
Immune Deficiency Foundation
Website
https://primaryimmune.org
Company type
Private
Founded year
1980
Operating status
Operating
Headcount range
11–50 employees
Short description
Immune Deficiency Foundation is a 501(c)(3) nonprofit patient organization founded in 1980, dedicated to improving diagnosis, treatment, and quality of life for individuals and families affected by primary immunodeficiency (PI). It delivers free education, peer support, clinical navigation, research grants, and policy advocacy at national scale.
Ownership category
akta.pro rank

Immune Deficiency Foundation industry classification

Industry
Product category
Nonprofit Patient Advocacy Services
NAICS
Voluntary Health Organizations (813212)
SIC
Services-Social Services (8300), Services-Misc Health & Allied Services, Nec (8090)
akta.pro primary industry
Rare Disease & Special Needs Support Organizations (BPAGACAM)
akta.pro secondary industries
Primary Immunodeficiency (PID) & Immune Deficiency Clinics (HLAKAAAI), Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

  • Patient advocacy services
  • Rare disease education
  • Immune deficiency support
  • Nonprofit healthcare research
  • Community peer support

Where Immune Deficiency Foundation is headquartered

Location

Headquarters

HQ city
Towson
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Immune Deficiency Foundation business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Donations and Fundraising: The IDF operates as a 501(c)(3) non-profit organization (EIN: 52-1214782) that relies on donations from individuals, families, and supporters to fund its resources, services, and outreach programs.

Distribution channels3 records

Marketing channels7 records

Immune Deficiency Foundation product offering

Product offering

Core offering

The Immune Deficiency Foundation is a national nonprofit patient organization that improves the diagnosis, treatment, and quality of life for people with primary immunodeficiency through free educational resources (handbooks, podcasts), peer support programs (Ask IDF helpline, peer groups, IDF Friends), patient-to-clinician connection tools (clinician finder, self-assessment), awareness/fundraising campaigns (Walk for PI, Plasma Hero), and research grant funding.

Product overview

The Immune Deficiency Foundation offers a comprehensive suite of educational, support, and research services for individuals affected by primary immunodeficiency (PI). The core offerings include the IDF Patient & Family Handbook (print resource), the IDF Podcast series with sub-series Undiagnosed and Bold Conversations, and the Ask IDF expert consultation service. Community support is provided through the IDF Friends online community and Get Connected peer groups. The Foundation provides diagnostic tools including an immune system self-assessment and a Clinician Finder database. Research initiatives include a Research Grant Program and community surveys. Awareness efforts feature the Plasma Hero campaign, the annual Walk and Community Days events, and the documentary 'Compromised: Life Without Immunity' available on YouTube. All services are funded primarily through donor contributions.

Differentiator

Problem solved

Functional benefit

Brands

  • Think Zebra: IDF's motto and awareness campaign. People with primary immunodeficiencies are like the zebras of the medical world—rare and worthy of attention and care.

Products and services

  • Patient & Family Handbook A comprehensive educational resource that explains primary immunodeficiency diseases, treatment options such as immunoglobulin therapy, and daily living guidance for patients and their families.
  • IDF Podcast An audio podcast that delivers educational content, patient stories, and expert interviews to the primary immunodeficiency community.
  • Ask IDF Support Service A direct support service that allows patients, families, and caregivers to ask questions and receive guidance on primary immunodeficiency-related issues.
  • Peer Support Groups Peer-led support groups that connect patients and families affected by primary immunodeficiency for shared experience, encouragement, and community connection.
  • IDF Friends / Get Connected Community A community-building program that connects patients and families affected by primary immunodeficiency through informal friendship and connection opportunities.
  • IDF Research Grants Program A research-grant program that funds scientific investigation into primary immunodeficiency diseases to advance diagnosis, treatment, and patient outcomes.
  • Walk for PI and Community Days Grassroots fundraising and awareness walk events held in local communities across the United States to support IDF's mission and raise primary immunodeficiency awareness.
  • Plasma Hero Awareness Campaign A public awareness campaign that highlights the importance of plasma donors in supporting treatment for primary immunodeficiency patients and encourages plasma donation.
  • Clinician Finder Tool An online directory that helps patients locate clinicians and immunologists experienced in diagnosing and treating primary immunodeficiency diseases.
  • Primary Immunodeficiency Self-Assessment Tool An online self-assessment tool that helps individuals evaluate whether they may be experiencing symptoms of primary immunodeficiency and guides next steps such as clinical evaluation.

Companies that use Immune Deficiency Foundation

Customer profile

Segments4 records

Ideal customer profiles4 records

Immune Deficiency Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Immune Deficiency Foundation partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor, major and core.

  • Mediaplanet (Rare Diseases Campaign)minorGTM or Marketing Partner · 13 March 2026Nationwide Rare Diseases campaign launched by Mediaplanet to raise awareness, promote early diagnosis, and improve treatment options for rare diseases. Involves collaboration between researchers, patient advocates, healthcare institutions, and pharmaceutical companies.
  • CDawgVA (Connor Colquhoun) and VTuber IronmousemajorGTM or Marketing PartnerContent creator partnership where Connor Colquhoun (CDawgVA) and Ironmouse, a VTuber living with common variable immune deficiency (CVID), came together to support IDF. What began as a friendship has grown into one of the most impactful partnerships in content creator fundraising, helping raise awareness and funds for the immunocompromised community.
  • Immunocompromised CollaborativecoreStrategic or Co-development PartnerCoalition of organizations joining forces to protect the most vulnerable against infectious disease. IDF participates as a member organization working collaboratively on policy advocacy and awareness initiatives.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Immune Deficiency Foundation competitors and assessment

Company assessment

Direct peers

  • Jeffrey Modell Foundation: Also dedicated specifically to primary immunodeficiency; operates a global network of diagnostic and research centers. Closest direct peer given the shared PI-only mission, fundraising model, and research-grant funding approach.
  • Cystic Fibrosis Foundation: Patient advocacy nonprofit for a single rare genetic disease with analogous programs: research grants, clinician finder, community walks, newborn screening advocacy, and significant pharma partnerships. Strong operating-model comparable despite a much larger budget.
  • Muscular Dystrophy Association: Long-standing rare disease nonprofit running patient services, research grants, clinical care networks, and signature fundraising events (telethons, walks). Comparable mission, multi-disease research portfolio, and donor-driven model.
  • National Organization for Rare Disorders (NORD): Umbrella advocacy organization for all rare diseases; IDF is a NORD member. Overlaps heavily in policy advocacy, research grants, and patient services but from a horizontal (all rare diseases) rather than vertical (PI-only) position.

Broad incumbents

  • Leukemia & Lymphoma Society: Disease-specific nonprofit at much larger scale, with peer support, research grants, clinician finder, and signature fundraising events (Light The Night). Comparable playbook though it operates across blood cancers rather than a single rare category.

Emerging players

  • American Autoimmune Related Diseases Association: Patient advocacy for autoimmune diseases, several of which overlap clinically with PI (autoimmunity is a known feature of many PI subtypes). Comparable smaller-scale nonprofit model with focus on disease-specific education and advocacy.
  • Alpha-1 Foundation: Patient advocacy nonprofit for Alpha-1 antitrypsin deficiency, another rare genetic disorder often managed by immunologists. Highly comparable single-disease nonprofit operating model at a smaller scale than IDF.

Regional players

Others

  • Plasma Protein Therapeutics Association (PPTA): Industry association representing plasma collection and fractionation companies that manufacture immunoglobulin replacement therapy used by many PI patients. Adjacent ecosystem participant rather than a competitor; relevant given IDF's Plasma Hero campaign.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Immune Deficiency Foundation social profiles

Digital presence

Immune Deficiency Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Immune Deficiency Foundation leadership team

Management profile

Number of profiles

Profiles1 record

Immune Deficiency Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Immune Deficiency Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Immune Deficiency Foundation

What does Immune Deficiency Foundation do?

The Immune Deficiency Foundation is a national nonprofit patient organization that improves the diagnosis, treatment, and quality of life for people with primary immunodeficiency through free educational resources (handbooks, podcasts), peer support programs (Ask IDF helpline, peer groups, IDF Friends), patient-to-clinician connection tools (clinician finder, self-assessment), awareness/fundraising campaigns (Walk for PI, Plasma Hero), and research grant funding.

Is Immune Deficiency Foundation a public or private company?

Immune Deficiency Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Immune Deficiency Foundation founded?

Immune Deficiency Foundation was founded in 1980. It employs 11 to 50 people.

Where is Immune Deficiency Foundation based?

Immune Deficiency Foundation is headquartered in Towson, United States, in the North America region.

How does Immune Deficiency Foundation make money?

One revenue line is on record: donations and Fundraising.

Who are Immune Deficiency Foundation's main competitors?

Direct peers on record are Jeffrey Modell Foundation, Cystic Fibrosis Foundation, Muscular Dystrophy Association and National Organization for Rare Disorders (NORD). Leukemia & Lymphoma Society is listed as a broad incumbent. Emerging players are American Autoimmune Related Diseases Association and Alpha-1 Foundation. Regional players are International Patient Organisation for Primary Immunodeficiencies (IPOPI) and Immune Deficiencies Foundation of Australia (IDFA). Plasma Protein Therapeutics Association (PPTA) is listed as an others.

Does Immune Deficiency Foundation have an API?

No public API is recorded for Immune Deficiency Foundation.

What industry is Immune Deficiency Foundation in?

Immune Deficiency Foundation's product category is Nonprofit Patient Advocacy Services. Its primary akta.pro industry code is BPAGACAM, Rare Disease & Special Needs Support Organizations, with a secondary code of HLAKAAAI, Primary Immunodeficiency (PID) & Immune Deficiency Clinics. Its NAICS code is 813212 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
KotakuTwitch Fans Spark $30K Bidding War Over Chance To Game With PokimaneTwitch streamer Pokimane auctioned a one-on-one gaming session for charity, with bids reaching $500,000. The auction, organized by YouTuber CDawgVA, was for the Immune Deficiency Foundation, and bids were wiped and restored. The auction ends July 19.PR NewswireImmune Deficiency Foundation holds virtual Primary Immunodeficiency ConferenceThe Immune Deficiency Foundation (IDF) announced its 2023 virtual Primary Immunodeficiency Conference, a two-decade-old annual event bringing together patients, families, and medical experts to discuss rare chronic immune conditions. The conference features three educational tracks, a fireside chat with Academy Award-nominated producer Emily V. Gordon about her diagnoses of Still's disease and CVID, and sessions led by immunologists and life management experts. Primary immunodeficiencies comprise over 450 rare conditions affecting approximately 500,000 individuals in the United States, according to the National Institutes of Health.PR NewswireNational Patient Organizations Join Forces to Ensure Copay Assistance Counts for PatientsThe Immune Deficiency Foundation joined 75 national patient and provider advocacy groups in the All Copays Count Coalition to support the reintroduction of the Help Ensure Lower Patient (HELP) Copays Act (H.R. 830), bipartisan federal legislation requiring insurers and pharmacy benefit managers to count copay assistance toward patient cost-sharing requirements. The legislation addresses copay accumulator adjustment policies that allow health plans and PBMs to exclude assistance from deductibles, leaving patients facing unexpected costs at the pharmacy. According to a 2023 report from The AIDS Institute, at least 64% of health plans include such policies, with more than half of plans in 24 states affected.PR NewswireBPL Supports the Immune Deficiency Foundation Research Grant Program for Second Year in a RowBio Products Laboratory (BPL) announced its continued support of the Immune Deficiency Foundation (IDF) Research Grant Program for the second consecutive year, funding patient-oriented research on primary immunodeficiencies. The research grants are designed to improve treatment, health, management, or diagnosis of the over 450 rare chronic disorders classified as primary immunodeficiencies. BPL, a manufacturer of plasma-derived protein therapies headquartered in the UK with US offices in Durham, North Carolina, became part of Kedrion Group in September 2022.CslZebra Pride in FebruaryThe zebra icon, originally from a University of Maryland physician's advice to think of horses not zebras, was repurposed by rare disease advocates to represent rare conditions. Rare Disease Day is observed on February 28, with groups like the Immune Deficiency Foundation using the zebra as a mascot. Advocates seek better access to specialists and research for the 7,000 identified rare conditions.PR NewswireImmune Deficiency Foundation Names Jorey Berry as President & CEOThe Immune Deficiency Foundation announced Jorey Berry as its new President & CEO, effective January 3, 2022. Berry brings over 20 years of nonprofit leadership experience, most recently serving as Vice President of Change Management at March of Dimes, along with prior government relations experience. She expressed eagerness to advance IDF's advocacy, education, and research initiatives for the approximately 250,000 people affected by primary immunodeficiency in the U.S.PR NewswireImmune Deficiency Foundation Launches White Paper Challenge Seeking New Ideas to Shorten the Time to Diagnosis and Expanding Awareness in Communities of ColorThe Immune Deficiency Foundation (IDF) announced a White Paper Challenge offering $10,000 awards for novel approaches to expand awareness in communities of color, increase equity in clinical trials, and shorten the time between diagnosis and treatment for primary immunodeficiency patients. The foundation also opened applications for seed grants of $25,000-$50,000 for U.S.-based researchers focusing on microbiome research, quality of life metrics, and big data analytics for early diagnosis. Applications for both funding opportunities must be submitted by December 15, 2021.PR NewswireImmune Deficiency Foundation Continues to Expand Spanish Language Resources as Part of Increased Commitment to Reaching Underserved CommunitiesThe Immune Deficiency Foundation (IDF) announced the expansion of its Spanish language resources and programming to better serve the growing Latino and Spanish-speaking community in the United States, hosting its first-ever virtual education session conducted entirely in Spanish. The session, presented by Dr. Vivian Hernandez-Trujillo, attracted more than 120 participants from 22 states, and IDF's upcoming PI Conference will feature multiple sessions in Spanish along with the launch of a Spanish-language virtual support group. The organization stated this effort is part of ongoing initiatives to reduce diagnostic delays for primary immunodeficiency, particularly among minority and underserved populations.PR NewswireImmune Deficiency Foundation Statement on "Everything, Everything"The Immune Deficiency Foundation issued a statement criticizing the film 'Everything, Everything' for misrepresenting Severe Combined Immune Deficiency (SCID), a rare genetic immunodeficiency, in an upcoming release from MGM Studios and Warner Bros. Pictures. The IDF specifically objects to the film's use of outdated stereotypes depicting SCID patients in sterile bubbles, inaccurate portrayals of the condition causing allergies, and a plot twist implying the protagonist was a victim of Munchausen syndrome by proxy. The organization argues these misrepresentations are harmful to patients who have sought SCID diagnoses and could reinforce dismissive attitudes from healthcare providers.PR NewswireImmune Deficiency Foundation Continues Partnership with Clinical Immunology Society to Promote National Primary Immunodeficiency Awareness Month and World PI Week in AprilThe Immune Deficiency Foundation (IDF) and Clinical Immunology Society (CIS) announced their second annual partnership to promote National Primary Immunodeficiency Awareness Month in April 2017 and World PI Week (April 22-29). The organizations aim to raise awareness about primary immunodeficiency diseases affecting approximately 250,000 diagnosed individuals in the U.S. and improve access to immunoglobulin replacement therapy, which varies significantly across regions globally. The CIS Annual Meeting in Seattle (March 23-26) served as the kick-off for Awareness Month, where new research findings were presented to over 600 attendees.